Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prevalence and Clinical Significance of Drug-Drug and Drug-Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece. | Pharmaceutics | 2021 | 33572247 | PubTator, text mining | PubMed |
| A narrative review of near-infrared fluorescence imaging in hepatectomy for hepatocellular carcinoma. | Ann Transl Med | 2021 | 33569473 | PubTator, text mining | PubMed |
| Quantitative protein expression of blood-brain barrier transporters in the vasculature of brain metastases of patients with lung and breast cancer. | Clin Transl Sci | 2021 | 33566445 | PubTator, text mining | PubMed |
| Feasibility of Extrapolating Randomly Taken Plasma Samples to Trough Levels for Therapeutic Drug Monitoring Purposes of Small Molecule Kinase Inhibitors. | Pharmaceuticals (Basel) | 2021 | 33557114 | PubTator, text mining | PubMed |
| Model-Informed Drug Development for Anti-Infectives: State of the Art and Future. | Clin Pharmacol Ther | 2021 | 33555032 | PubTator, text mining | PubMed |
| Protein Phosphatase 1 Regulatory Subunit 3B Genotype at rs4240624 Has a Major Effect on Gallbladder Bile Composition. | Hepatol Commun | 2021 | 33553972 | PubTator, text mining | PubMed |
| Hepatobiliary phase hypointensity on gadobenate dimeglumine-enhanced magnetic resonance imaging may improve the diagnosis of hepatocellular carcinoma. | Ann Transl Med | 2021 | 33553348 | PubTator, text mining | PubMed |
| An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation. | Radiol Oncol | 2021 | 33544992 | PubTator, text mining | PubMed |
| Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate. | Proc Natl Acad Sci U S A | 2021 | 33542154 | PubTator, text mining | PubMed |
| Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg-1 rifampicin. | Eur Respir J | 2021 | 33542056 | PubTator, text mining | PubMed |
| Drug-Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C. | Int J Gen Med | 2021 | 33536776 | PubTator, text mining | PubMed |
| Drug Disposition in the Lower Gastrointestinal Tract: Targeting and Monitoring. | Pharmaceutics | 2021 | 33530468 | PubTator, text mining | PubMed |
| How Semiphysiological Population Pharmacokinetic Modeling Incorporating Active Hepatic Uptake Supports Phase II Dose Selection of RO7049389, A Novel Anti-Hepatitis B Virus Drug. | Clin Pharmacol Ther | 2021 | 33523474 | PubTator, text mining | PubMed |
| In-silico network-based analysis of drugs used against COVID-19: Human well-being study. | Saudi J Biol Sci | 2021 | 33519272 | PubTator, text mining | PubMed |
| Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias. | J Pers Med | 2021 | 33513899 | PubTator, text mining | PubMed |
| Fluorescent Detection of Vestibular Schwannoma Using Intravenous Sodium Fluorescein In Vivo. | Otol Neurotol | 2021 | 33492057 | PubTator, text mining | PubMed |
| Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2. | Br J Nutr | 2021 | 33468263 | PubTator, text mining | PubMed |
| Pyrrolizidine Alkaloids Disturb Bile Acid Homeostasis in the Human Hepatoma Cell Line HepaRG. | Foods | 2021 | 33466663 | PubTator, text mining | PubMed |
| Determination of Intraprostatic and Intratesticular Androgens. | Int J Mol Sci | 2021 | 33466491 | PubTator, text mining | PubMed |
| Application of Individualized PBPK Modeling of Rate Data to Evaluate the Effect of Hemodialysis on Nonrenal Clearance Pathways. | J Clin Pharmacol | 2021 | 33459400 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=45